Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped ...
GLP-1 drugs such as Wegovy, Ozempic, and Zepbound are a class of medications primarily taken to treat Type 2 diabetes and, more recently, obesity. Research indicates many people taking GLP-1s for ...
Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss treatment long enough.
Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new ...
New blockbuster GLP-1 drugs such as Ozempic and Mounjaro are perhaps the most effective drugs ever developed for type 2 diabetes and obesity. They could also have a transformative effect in the ...
Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and Type 2 diabetes, a new study says.